KLRK1 and cancer: This strategy phenocopied miR-181a overexpression, which negatively regulated NKG2D expression in peripheral blood T cells at both the mRNA and protein levels, with the consequence of pathophysiological implications in cancer immunity and inflammatory disease settings.